Infinium Global Research Oncology Biosimilars Market | Page 2

A latest report has been added to the wide database of Oncology Biosimilars Market by Infinium Global Research. This report studies
the Oncology Biosimilars Market by application (cancer treatment drugs and supportive care drugs), end-user (hospitals and retail
pharmacies) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of the study
is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. Oncology
Biosimilars Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive
landscape, latest trends, and product offerings of the major companies in the Oncology Biosimilars Market. According to report the
global oncology biosimilars market is projected to grow at a CAGR of 32.4% over the forecast period of 2018-2024.
Segment Covered
The report on global oncology biosimilars market covers segments such as, application and end-user. On the basis of application the
global oncology biosimilars market is categorized into cancer treatment drugs and supportive care drugs. On the basis of end-user the
global oncology biosimilars market is categorized into hospitals and retail pharmacies.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each geography is provided over the period of 2016-2024. The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the
growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the
market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a
CAGR of x.x% over the period of 2018-2024.
Companies Profiled:
The report provides profiles of the companies in the global oncology biosimilars market such as, Sandoz, Amgen, Biocon, Hospira, F
Hoffmann-La Roche, Cipla, Dr Reddy's Laboratories, Pfizer, Baxter and Sanofi.